BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3145722)

  • 1. [Intermediate myocardial metabolism. Changes in ischemia, diabetes and hyperthyroidism].
    Feuvray D; Khandoudi N; Lagadic-Gossmann D; Besse S
    Arch Mal Coeur Vaiss; 1988 Oct; 81 Spec No():29-33. PubMed ID: 3145722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Metabolism of long chain fatty acids in the normal and pathologic heart: effects of ischemia].
    Feuvray D; Leblond Y
    Diabete Metab; 1984 Dec; 10(5):316-23. PubMed ID: 6397367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Myocardial metabolism abnormalities during ischemia and reperfusion].
    Argaud L; Ovize M
    Arch Mal Coeur Vaiss; 2000 Jan; 93(1):87-90. PubMed ID: 11227723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on experimental coronary insufficiency. Effect of L-carnitine on myocardial ischemia produced by sympathetic-nerve stimulation with high plasma fatty acids.
    Iimura O; Shoji T; Yoshida S; Sato R; Nohara K; Kudoh Y; Ishiyama N; Motoe M
    Adv Myocardiol; 1985; 6():437-49. PubMed ID: 3992042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic products and myocardial ischemia.
    Neely JR; Feuvray D
    Am J Pathol; 1981 Feb; 102(2):282-91. PubMed ID: 7008624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation of unsaturated acylcarnitine molecular species during acute myocardial ischemia: metabolic compartmentalization of products of fatty acyl chain elongation in the acylcarnitine pool.
    Ford DA; Han X; Horner CC; Gross RW
    Biochemistry; 1996 Jun; 35(24):7903-9. PubMed ID: 8672492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An imbalance between glycolysis and glucose oxidation is a possible explanation for the detrimental effects of high levels of fatty acids during aerobic reperfusion of ischemic hearts.
    Lopaschuk GD; Wambolt RB; Barr RL
    J Pharmacol Exp Ther; 1993 Jan; 264(1):135-44. PubMed ID: 8380856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in myocardial fatty acid metabolism contribute to ischemic injury in the diabetic.
    Lopaschuk GD
    Can J Cardiol; 1989 Sep; 5(6):315-20. PubMed ID: 2676122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malonyl coenzyme a decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation.
    Dyck JR; Cheng JF; Stanley WC; Barr R; Chandler MP; Brown S; Wallace D; Arrhenius T; Harmon C; Yang G; Nadzan AM; Lopaschuk GD
    Circ Res; 2004 May; 94(9):e78-84. PubMed ID: 15105298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic therapy for patients with diabetes mellitus and coronary artery disease.
    Rosano GM; Vitale C; Fragasso G
    Am J Cardiol; 2006 Sep; 98(5A):14J-18J. PubMed ID: 16931201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of L-carnitine on mitochondrial acyl CoA esters in the ischemic dog heart.
    Kobayashi A; Fujisawa S
    J Mol Cell Cardiol; 1994 Apr; 26(4):499-508. PubMed ID: 8072006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic disarrangement in ischemic heart disease and its therapeutic control.
    Ferrari R
    Rev Port Cardiol; 1998 Sep; 17(9):667-84. PubMed ID: 9834638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical derangements in ischemic myocardium: the role of carnitine.
    Siliprandi N; Di Lisa F; Toninello A
    G Ital Cardiol; 1984 Oct; 14(10):804-8. PubMed ID: 6240423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic energy metabolism in diabetes: therapeutic implications.
    Pogatsa G
    Coron Artery Dis; 2001 Feb; 12 Suppl 1():S29-33. PubMed ID: 11286305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of energy production in myocardial ischemia.
    Shrago E; Shug AL; Sul H; Bittar N; Folts JD
    Circ Res; 1976 May; 38(5 Suppl 1):I75-9. PubMed ID: 1269092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aerobic vs anaerobic metabolism during ischemia in heart muscle.
    Das DK; Engelman RM; Rousou JA; Breyer RH
    Ann Chir Gynaecol; 1987; 76(1):68-76. PubMed ID: 3592561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Free radical-mediated damage during myocardial ischemia and reperfusion and protection by carnitine esters.
    Subramanian R; Plehn S; Noonan J; Schmidt M; Shug AL
    Z Kardiol; 1987; 76 Suppl 5():41-5. PubMed ID: 3433882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the roles of long-chain acyl carnitine accumulation and impaired glucose utilization in ischaemic contracture development and tissue damage in the guinea-pig heart.
    Clarke B; Wyatt KM; May GR; McCormack JG
    J Mol Cell Cardiol; 1996 Jan; 28(1):171-81. PubMed ID: 8745225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The heart in diabetics].
    Bĕlobrádková J; Filipenský B
    Vnitr Lek; 2003 Dec; 49(12):921-6. PubMed ID: 15040156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac energetics during ischaemia and the rationale for metabolic interventions.
    Stanley WC
    Coron Artery Dis; 2001 Feb; 12 Suppl 1():S3-7. PubMed ID: 11286306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.